Half-year report · HY

Period2026-01-01 → 2026-06-30
Filed2026-08-06
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥43.7bn2026-01-01 → 2026-06-30Cons.Net sales
Revenue¥87.6bn2025-01-01 → 2025-12-31Cons.Net sales (5-year summary)
Revenue¥42.3bn2025-01-01 → 2025-06-30Cons.Net sales
Operating income¥2.6bn2026-01-01 → 2026-06-30Cons.Operating income
Operating income¥2.3bn2025-01-01 → 2025-06-30Cons.Operating income
Ordinary income¥2.6bn2026-01-01 → 2026-06-30Cons.Ordinary income
Ordinary income¥4.3bn2025-01-01 → 2025-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥2.4bn2025-01-01 → 2025-06-30Cons.Ordinary income
Profit before tax¥2.7bn2026-01-01 → 2026-06-30Cons.Income before income taxes
Profit before tax¥2.5bn2025-01-01 → 2025-06-30Cons.Income before income taxes
Net income (owners)¥2.0bn2026-01-01 → 2026-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥3.1bn2025-01-01 → 2025-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.9bn2025-01-01 → 2025-06-30Cons.Profit loss attributable to owners of parent
Net income¥2.0bn2026-01-01 → 2026-06-30Cons.Profit loss
Net income¥1.9bn2025-01-01 → 2025-06-30Cons.Profit loss
Total assets¥55.8bnat 2026-06-30Cons.Assets
Total assets¥59.2bnat 2025-12-31Cons.Assets
Total assets¥53.9bnat 2025-06-30Cons.Total assets (5-year summary)
Total liabilities¥27.6bnat 2026-06-30Cons.Liabilities
Total liabilities¥32.3bnat 2025-12-31Cons.Liabilities
Net assets / equity¥28.2bnat 2026-06-30Cons.Net assets
Net assets / equity¥27.0bnat 2025-12-31Cons.Net assets
Net assets / equity¥25.5bnat 2025-06-30Cons.Net assets (5-year summary)
Cash and deposits¥831mat 2026-06-30Cons.Cash and deposits
Cash and deposits¥884mat 2025-12-31Cons.Cash and deposits
Cash & equivalents¥826mat 2026-06-30Cons.Cash and cash equivalents
Cash & equivalents¥879mat 2025-12-31Cons.Cash and cash equivalents
Cash & equivalents¥797mat 2025-06-30Cons.Cash and cash equivalents
Cash & equivalents¥882mat 2024-12-31vCons.Cash and cash equivalents
Operating cash flow¥35m2026-01-01 → 2026-06-30Cons.Net cash provided by used in operating activities
Operating cash flow¥3.6bn2025-01-01 → 2025-12-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥377m2025-01-01 → 2025-06-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥1.1bn2026-01-01 → 2026-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.9bn2025-01-01 → 2025-12-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.2bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in investment activities
Financing cash flow¥1.0bn2026-01-01 → 2026-06-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥1.6bn2025-01-01 → 2025-12-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.5bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in financing activities
EPS (basic)¥35.062026-01-01 → 2026-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥54.722025-01-01 → 2025-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥32.572025-01-01 → 2025-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio49.2%at 2026-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio44.2%at 2025-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio45.7%at 2025-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 39
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2026-01-01 → 2026-06-30¥43m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2026-01-01 → 2026-06-30¥43m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2026-01-01 → 2026-06-30¥5m
Reconciling Itemsreconcilingrevenue2026-01-01 → 2026-06-30−¥6m
Reconciling Itemsreconcilingrevenue intersegment2026-01-01 → 2026-06-30−¥6m
Enzymatic Medicinereportable segmentrevenue2026-01-01 → 2026-06-30¥3.0bn
Enzymatic Medicinereportable segmentrevenue external2026-01-01 → 2026-06-30¥3.0bn
Enzymatic Medicinereportable segmentsegment profit2026-01-01 → 2026-06-30¥936m
Liquorreportable segmentrevenue2026-01-01 → 2026-06-30¥40.0bn
Liquorreportable segmentrevenue external2026-01-01 → 2026-06-30¥40.0bn
Liquorreportable segmentrevenue intersegment2026-01-01 → 2026-06-30¥6m
Liquorreportable segmentsegment profit2026-01-01 → 2026-06-30¥1.2bn
Real Estatereportable segmentrevenue2026-01-01 → 2026-06-30¥665m
Real Estatereportable segmentrevenue external2026-01-01 → 2026-06-30¥665m
Real Estatereportable segmentsegment profit2026-01-01 → 2026-06-30¥396m
—segment totalrevenue2026-01-01 → 2026-06-30¥43.6bn
—segment totalrevenue external2026-01-01 → 2026-06-30¥43.6bn
—segment totalrevenue intersegment2026-01-01 → 2026-06-30¥6m
—segment totalsegment profit2026-01-01 → 2026-06-30¥2.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2025-01-01 → 2025-06-30¥49m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2025-01-01 → 2025-06-30¥44m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2025-01-01 → 2025-06-30¥5m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2025-01-01 → 2025-06-30¥6m
Reconciling Itemsreconcilingrevenue2025-01-01 → 2025-06-30−¥17m
Reconciling Itemsreconcilingrevenue intersegment2025-01-01 → 2025-06-30−¥17m
Enzymatic Medicinereportable segmentrevenue2025-01-01 → 2025-06-30¥2.5bn
Enzymatic Medicinereportable segmentrevenue external2025-01-01 → 2025-06-30¥2.5bn
Enzymatic Medicinereportable segmentsegment profit2025-01-01 → 2025-06-30¥568m
Liquorreportable segmentrevenue2025-01-01 → 2025-06-30¥39.1bn
Liquorreportable segmentrevenue external2025-01-01 → 2025-06-30¥39.0bn
Liquorreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥12m
Liquorreportable segmentsegment profit2025-01-01 → 2025-06-30¥1.4bn
Real Estatereportable segmentrevenue2025-01-01 → 2025-06-30¥660m
Real Estatereportable segmentrevenue external2025-01-01 → 2025-06-30¥660m
Real Estatereportable segmentsegment profit2025-01-01 → 2025-06-30¥389m
—segment totalrevenue2025-01-01 → 2025-06-30¥42.2bn
—segment totalrevenue external2025-01-01 → 2025-06-30¥42.2bn
—segment totalrevenue intersegment2025-01-01 → 2025-06-30¥12m
—segment totalsegment profit2025-01-01 → 2025-06-30¥2.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 577
ItemContextValueUnit
Increase decrease in net defined benefit liability ope cfPrior1InterimDuration29000000JPY
Increase decrease in net defined benefit liability ope cfInterimDuration29000000JPY
Increase decrease in allowance for doubtful accounts ope cfPrior1InterimDuration-2000000JPY
Increase decrease in allowance for doubtful accounts ope cfInterimDuration-4000000JPY
Increase decrease in provision for directors bonuses ope cfPrior1InterimDuration-24000000JPY
Increase decrease in provision for directors bonuses ope cfInterimDuration-15000000JPY
Increase decrease in provision for share based remuneration for directors and other officers ope cfPrior1InterimDuration-78000000JPY
Increase decrease in provision for share based remuneration for directors and other officers ope cfInterimDuration5000000JPY
Increase decrease in provision for shareholder benefit program ope cfPrior1InterimDuration-24000000JPY
Increase decrease in provision for shareholder benefit program ope cfInterimDuration-19000000JPY
Interest and dividends income ope cfPrior1InterimDuration-46000000JPY
Interest and dividends income ope cfInterimDuration-56000000JPY
Interest expenses ope cfPrior1InterimDuration64000000JPY
Interest expenses ope cfInterimDuration76000000JPY
Equity in earnings losses of affiliates ope cfPrior1InterimDuration-69000000JPY
Equity in earnings losses of affiliates ope cfInterimDuration-53000000JPY
Gain on sales of non current assets ope cfPrior1InterimDuration-119000000JPY
Gain on sales of non current assets ope cfInterimDuration-69000000JPY
Loss on sales and retirement of noncurrent assets ope cfPrior1InterimDuration15000000JPY
Loss on sales and retirement of noncurrent assets ope cfInterimDuration31000000JPY
Loss gain on sales of investment securities ope cfPrior1InterimDuration-JPY
Loss gain on sales of investment securities ope cfInterimDuration-19000000JPY
Loss gain on cancellation of insurance contract ope cfPrior1InterimDuration8000000JPY
Loss gain on cancellation of insurance contract ope cfInterimDuration-JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1InterimDuration1609000000JPY
Decrease increase in notes and accounts receivable trade ope cfInterimDuration5037000000JPY
Decrease increase in inventories ope cfPrior1InterimDuration-371000000JPY
Decrease increase in inventories ope cfInterimDuration-1829000000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1InterimDuration-344000000JPY
Increase decrease in notes and accounts payable trade ope cfInterimDuration-981000000JPY
Increase decrease in accrued consumption taxes ope cfPrior1InterimDuration-336000000JPY
Increase decrease in accrued consumption taxes ope cfInterimDuration-634000000JPY
Increase decrease in accrued liquor tax ope cfPrior1InterimDuration-3130000000JPY
Increase decrease in accrued liquor tax ope cfInterimDuration-3728000000JPY
Other net ope cfPrior1InterimDuration-670000000JPY
Other net ope cfInterimDuration-906000000JPY
Subtotal ope cfPrior1InterimDuration-33000000JPY
Subtotal ope cfInterimDuration591000000JPY
Interest and dividends income received ope cf inv cfPrior1InterimDuration197000000JPY
Interest and dividends income received ope cf inv cfInterimDuration201000000JPY
Interest expenses paid ope cf fin cfPrior1InterimDuration-83000000JPY
Interest expenses paid ope cf fin cfInterimDuration-98000000JPY
Proceeds from insurance income ope cfPrior1InterimDuration80000000JPY
Proceeds from insurance income ope cfInterimDuration-JPY
Income taxes paid refund ope cfPrior1InterimDuration-538000000JPY
Income taxes paid refund ope cfInterimDuration-658000000JPY
Net cash provided by used in operating activitiesPrior1InterimDuration-377000000JPY
Net cash provided by used in operating activitiesInterimDuration35000000JPY
Purchase of noncurrent assets inv cfPrior1InterimDuration-1234000000JPY
Purchase of noncurrent assets inv cfInterimDuration-1110000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2025-12-31pass
balance sheet identityconsolidated 2026-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2025-12-31pass
statement vs summary · net assetsconsolidated 2026-06-30pass
statement vs summary · net income attributable to parentconsolidated 2025-01-01/2025-06-30pass
statement vs summary · net income attributable to parentconsolidated 2026-01-01/2026-06-30pass
statement vs summary · operating cash flowconsolidated 2025-01-01/2025-06-30pass
statement vs summary · operating cash flowconsolidated 2026-01-01/2026-06-30pass
statement vs summary · revenueconsolidated 2025-01-01/2025-06-30pass
statement vs summary · revenueconsolidated 2026-01-01/2026-06-30pass
statement vs summary · total assetsconsolidated 2025-12-31pass
statement vs summary · total assetsconsolidated 2026-06-30pass